Table 2.
Colchicine versus control—outcomes*
Colchicine group (n=1939) | Control group (n=1942) | Hazard ratio (95% CI) | p value | ||
---|---|---|---|---|---|
Hospitalisation or death† | 66 (3·4%) | 65 (3·3%) | 1·02 (0·72–1·43) | 0·93 | |
Hospitalisation or respiratory death | 65 (3·4%) | 65 (3·3%) | 1·00 (0·71–1·41) | 0·99 | |
Hospitalisation | 62 (3·2%) | 61 (3·1%) | 1·02 (0·71–1·45) | 0·92 | |
Death | 12 (0·6%) | 11 (0·6%) | 1·09 (0·48–2·47) | 0·84 | |
Respiratory death | 10 (0·5%) | 7 (0·4%) | 1·43 (0·54–3·75) | 0·47 |
Data are n (%) unless stated otherwise.
Any thrombosis occurred in three patients randomly assigned to colchicine and four randomly assigned to control. Pulmonary embolism occurred in one patient randomly assigned to colchicine and two randomly assigned to control.
Primary outcome.